The authors are from the David Geffen School of Medicine, University of California, Los Angeles. Dr. Cummings is a fellow, Department of Hematology-Oncology; Dr. Kaprealian is an assistant professor, Department of Radiation Oncology; Dr. Sarantopoulos is an assistant professor, Department of Anatomic Pathology; Ms. Mendenhall is a nurse practitioner, Department of Hematology-Oncology; and Dr. Goldman is the director of Clinical Trials in Thoracic Oncology and an assistant professor, Department of Hematology-Oncology.
Dr. Kennedy is physician-in-chief, Radiation Oncology, Sarah Cannon, Nashville, TN. Dr. Garwood is physician leader, Pulmonology, Sarah Cannon. Dr. Grow is physician leader, Radiation Oncology, Sarah Cannon; and North Florida Radiation Oncology, Gainesville, FL. Mr. Lipscomb is medical physics leader, Sarah Cannon.
Disclosure: Dr. Garwood is a consultant to Medtronic, Minneapolis, MN. The remaining authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.